首页|期刊导航|海南医科大学学报|二冬消渴方通过PI3K/AKT/mTOR通路调控泪腺自噬改善2型糖尿病干眼的机制

二冬消渴方通过PI3K/AKT/mTOR通路调控泪腺自噬改善2型糖尿病干眼的机制OA

Mechanisms of the regulation of lacrimal gland autophagy through the PI3K/AKT/mTOR pathway by Erdong Xiaoke Decoction to relieve dry eye in type 2 diabetes mellitus

中文摘要英文摘要

目的:探究二冬消渴方如何通过磷脂酰肌醇3-激酶(phosphatidylinositol 3-kinase,PI3K)/蛋白激酶 B(protein kinase B,AKT)/哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)通路调节泪腺自噬,从而改善糖尿病大鼠干眼状况的具体机制.方法:20只健康雄性SD大鼠随机分成对照组、模型组、中药组、阳药组,每组5只.对照组喂食标准饲料,其余各组大鼠喂食高糖高脂饲料,4周后腹腔注射链脲佐菌素,连续8周,构建2型糖尿病干眼大鼠模型.对照组和模型组予10 mL/kg生理盐水灌胃,中药组予11 g/kg二冬消渴方灌胃,阳药组予玻璃酸钠滴眼液滴双眼,连续4周.造模前、造模后、干预后比较各组大鼠角膜荧光染色(FL)、泪膜破裂时间(BUT)、酚红棉线试验(PRT)等干眼相关指标,取样后称量泪腺重量,H&E染色对泪腺进行病理学观察,透射电镜观察泪腺自噬小体,使用Western blot和RT-PCR技术检测泪腺中的PI3K、AKT、mTOR、微管相关蛋白 1轻链 3(LC3)、螯合体-1(SQSTM1/p62)蛋白和 mRNA表达情况.结果:造模后,除对照组外各组间干眼指标差异无统计学意义(P>0.05);与对照组比较,其余组 FL 升高,BUT、PRT降低(P<0.05).干预后,与对照组相比,模型组大鼠干眼明显,FL升高,BUT、PRT降低(P<0.05),泪腺重量减轻(P<0.05),H&E染色腺小叶萎缩,腺腔扩张,电镜下自噬小体减少,泪腺组织中PI3K、AKT、mTOR磷酸化激活且mRNA表达升高(P<0.05);与模型组比较,中药组、阳药组上述指标皆逆转(P<0.05).结论:二冬消渴方抑制糖尿病干眼大鼠泪腺中PI3K/AKT/mTOR通路激活,提高自噬水平以减轻泪腺损伤,进而缓解干眼.

Objective:To investigate the specific mechanism of how Erdong Xiaoke Decoction(EDXKD)regulates lacrimal gland autophagy through the phosphatidylinositol 3-kinase(PI3K)/protein kinase B(AKT)/mammalian target of rapamycin(mTOR)pathway,thereby improving the dry eye condition in diabetes rats.Methods:A total of 20 healthy male SD rats were randomly divided into the control group,the model group,the traditional Chinese medicine(TCM)group,and the prophylactic drug group,with 5 rats in each group.The rats in the control group were fed with standard diet,and the rats in the other groups were fed with high sugar and fat diet.After 4 weeks,streptozotocin(STZ)was injected intraperitoneally for 8 consecutive weeks to establish the model of type 2 diabetes dry eye rats.The control group and the model group were given 10 mL/kg physiological saline by gavage,the TCM group was given 11 g/kg EDXKD by gavage,and the prophylactic drug group was given sodium hyal-uronate eye drops in both eyes for 4 consecutive weeks.Before modeling,after modeling,and after intervention,dry eye related indicators such as corneal fluorescence staining(FL),tear film rupture time(BUT),and phenol red cotton thread test(PRT)were compared in each group of rats.After sampling,the weight of the lacrimal gland was measured,and H&E staining was used for pathological observation of the lacrimal gland.Transmission electron microscopy was used to observe autophagosomes in the lacrimal gland.And Western blot and RT-PCR techniques were used to detect the expression of PI3K,AKT,mTOR,microtu-bule associated protein 1 light chain 3(LC3),chelator-1(SQSTM1/p62)protein and mRNA in the lacrimal gland.Results:Af-ter modeling,there was no statistically significant difference in dry eye indicators among all groups except the control group(P>0.05).Compared to the control group,the other groups showed an increase in FL and a decrease in BUT and PRT(P<0.05).Af-ter intervention,compared to the control group,the model group rats showed significant dry eye symptoms,with an increase in FL,a decrease in BUT and PRT(P<0.05),a reduction in lacrimal gland weight(P<0.05),atrophy of H&E stained glandular lobules,dilation of glandular lumen,a decrease in autophagosomes under electron microscopy,and activation of PI3K,AKT,mTOR phosphorylation and increased mRNA expression in lacrimal gland tissue(P<0.05).Compared to the model group,both the TCM group and the prophylactic drug group showed a reversal of the above indicators(P<0.05).Conclusion:EDXKD inhib-its the activation of PI3K/AKT/mTOR pathway in lacrimal gland of diabetes dry eye rats,and increases autophagy level to allevi-ate lacrimal gland damage,thereby alleviating dry eye symptoms.

何璐平;石李;姬慧杰;孙心怡;高卫萍

南京中医药大学附属医院 眼科,江苏 南京 210024南京中医药大学附属医院 眼科,江苏 南京 210024南京中医药大学附属医院 眼科,江苏 南京 210024南京中医药大学附属医院 内分泌科,江苏 南京 210024南京中医药大学附属医院 眼科,江苏 南京 210024

医药卫生

二冬消渴方糖尿病干眼PI3K/AKT/mTOR通路泪腺自噬

Erdong Xiaoke Decoction(EDXKD)Diabetic dry eyePI3K/AKT/mTOR pathwayLacrimal glandAu-tophagy

《海南医科大学学报》 2026 (12)

917-924,8

This study was supported by National Natural Science Foundation of China(82474638)Cadre Healthcare Scientific Research Project of Jiangsu Provincial Health and Wellness Commission(BJ23012)A Traditional Chinese Medicine Compound with Treatment of Diabetic Dry Eye and Its Preparation Method and Application Patent(CN116637154A) 国家自然科学基金(82474638)江苏省卫生健康委干部保健科研项目(BJ23012)一种具有治疗糖尿病干眼症的中药复方及其制备方法与应用专利(CN116637154A)

10.13210/j.cnki.jhmu.20250307.001

评论